arrow
C

Casper H.J. van Eijck

Erasmus University Rotterdam
H指数:93
被引数:3.6万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Impact of pathological diagnosis on postoperative outcomes after pancreatoduodenectomy: A nationwide cohort study

胰腺十二指肠切除术后病理诊断对预后的影响:一项全国性队列研究

EJSO
IF2.9
2026-07-010
OAAI
Staging laparoscopy to detect occult metastases in localized pancreatic cancer: global survey among nine international societies

局部胰腺癌中用于检测隐匿性转移的分期腹腔镜:九个国际学会的全球调查

HPB
IF2.4
2025-12-060
OAAI
Delayed gastric emptying after pancreatic cancer surgery impacts time to start of adjuvant treatment but not overall survival: a post-hoc analysis of the PREOPANC-1 and-2 trials

胰腺癌手术后胃排空延迟影响辅助治疗开始时间,但不影响总生存期:一项对PREOPANC-1和-2试验的事后分析

2025-12-010
PRE
REACtiVe-2: phase I evaluation of dendritic cell vaccination and agonistic CD40 therapy following (m)FOLFIRINOX in metastatic pancreatic cancer

REACtiVe-2:树突状细胞疫苗接种和激动性CD40疗法在mFOLFIRINOX治疗后的I期评价,用于转移性胰腺癌

2025-11-280
OAAI
Timing of Adjuvant Chemotherapy in Patients with Pancreatic Ductal Adenocarcinoma: A Nationwide Analysis

胰腺导管腺癌患者辅助化疗时机的全国性分析

2025-11-050
OAAI
Clinical Relevance of Next-Generation Sequencing in Patients Aged 60 Years or Younger with Pancreatic Cancer: A Nationwide Prospective Cohort Study

下一代测序在60岁及以下胰腺癌患者中的临床意义:一项全国性前瞻性队列研究

2025-10-190
OAAI
Time-varying impact of established prognostic factors in resected pancreatic ductal adenocarcinoma

已建立的预后因素在切除的胰腺导管腺癌中的时变影响

2025-10-010
PRE
Neoadjuvant FOLFIRINOX versus neoadjuvant gemcitabine-based chemoradiotherapy in resectable and borderline resectable pancreatic cancer (PREOPANC-2): a multicentre, open-label, phase 3 randomised trial

新辅助FOLFIRINOX与基于吉西他滨的新辅助化放疗在可切除和边界可切除胰腺癌中的比较(PREOPANC-2):一项多中心、开放标签、III期随机试验

2025-09-100
PRE
ASO Visual Abstract: Blood Sample Collection in Randomized Controlled Trials for Biomarker Discovery and Validation: Experience of the PREOPANC-2 Trial
2025-04-010
PRE
Nationwide implementation of the international multidisciplinary best-practice for locally advanced pancreatic cancer (PREOPANC-4): study protocol
2025-02-190
OAAI
Blood Sample Collection in Randomized Controlled Trials for Biomarker Discovery and Validation: Experience of the PREOPANC-2 Trial
2025-02-051
OAAI
Long-Term Outcomes of Early Surgery vs Endoscopy First in Chronic Pancreatitis Follow-Up Analysis of the ESCAPE Randomized Clinical Trial
2025-02-011
OA
Root-cause analysis of mortality after pancreatic resection in a nationwide cohort

全国范围内胰腺切除术后死亡原因的根因分析

HPB
IF2.4
2024-12-011
PRE